The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure.

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to ...

Overall, though, the meta-analysis identified a reduction in ischemia—but not in hard outcomes—with early treatment.

Initial medical management of STEMI consists of relief of ischemic pain with nitrates and ... with systemic hypotension or with acute left heart decompensation. Long-term (lifetime) beta-blocker ...

A discovery in cardiac regeneration offers ew hope for the treatment of ischemic heart failure. Published in npj Regenerative ...

Researchers determine the role of dietary omega-3 fatty acids in the development of ischemic heart disease throughout the ...

with 87% of those being ischemic stroke. TNKase is one of Genentech’s cardiovascular staples, having been approved nearly 25 years ago for the treatment of heart attacks and acute myocardial ...

Peripheral Aneurysms and Artery Disorders: Some vascular diseases, like fibromuscular dysplasia, are much more common in ...

Aldosterone has been shown to cause coronary inflammation, cardiac hypertrophy, myocardial fibrosis, ventricular arrhythmias, and ischemic ... in the treatment of heart failure, including an ...

The symptoms of Takotsubo cardiomyopathy are the same as those seen in myocardial ischemia and congestive heart failure ... The mainstay of treatment is beta-blockers and, at least temporarily ...

The multi-continent collaborations led to a discovery that can revolutionise the use of current medicines that regulate ...